You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Claims for Patent: 9,623,088

✉ Email this page to a colleague

Summary for Patent: 9,623,088

Title:	Factor VIII polypeptide formulations
Abstract:	The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
Inventor(s):	Kevin Maloney, Daniel Gage, Ahmad Abdul-Fattah
Assignee:	Bioverativ Therapeutics Inc
Application Number:	US14/213,180

Details for Patent 9,623,088

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bioverativ Therapeutics, Inc.	ELOCTATE	antihemophilic factor (recombinant), fc fusion protein	For Injection	125487	June 06, 2014	⤷ Get Started Free	2034-03-14
Bioverativ Therapeutics, Inc.	ELOCTATE	antihemophilic factor (recombinant), fc fusion protein	For Injection	125487	January 27, 2017	⤷ Get Started Free	2034-03-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,623,088

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2014144795	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2014070953	⤷ Get Started Free
Uruguay	35462	⤷ Get Started Free
United States of America	2021069300	⤷ Get Started Free
United States of America	2017281734	⤷ Get Started Free
United States of America	2015266944	⤷ Get Started Free
United States of America	2014308280	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.